Dermatology
Conference Coverage
Pandemic puts patients with psoriatic disease off seeking medical help
Both the physical and mental health of people with psoriasis and psoriatic arthritis has been affected by the ongoing COVID-19 pandemic.
Conference Coverage
International expert group agrees on redefining psoriasis severity
“What we came up with is a very sensible approach to defining whether patients should get either topical or systemic therapy.”
Conference Coverage
What happened to melanoma care during COVID-19 sequestration
Preliminary evidence indicates delayed diagnosis and treatment measurably worsened outcome indicators.
News
Twelve medical groups pen letter opposing UHC copay accumulator program
“We see policies like this as sacrificing patients to the battle over high drug prices,” said Dr. Christopher Phillips.
FDA/CDC
OTC topical ivermectin lotion earns FDA approval for head lice
The drug is approved only for treating head lice, and should be used on the scalp and dry hair.
Conference Coverage
How to assess erythema in children with skin of color
News
Shingrix effective in older adults with preexisting immune-mediated disorders
The most common immune-mediated disorders in two phase 3 clinical trials of the vaccine were psoriasis, spondyloarthropathy, rheumatoid arthritis...
News
COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate
No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments...
Latest News
Melanoma experts say ‘no’ to routine gene profile testing
This test is not endorsed by the American Academy of Dermatology or National Comprehensive Cancer Network outside of studies.
Latest News
FDA approves topical antiandrogen for acne
Approval was based in part on a pair of phase 3, double-blind, vehicle-controlled, 12-week, randomized trials.